loading...| Preferred Name |
Azaserine |
|
| Synonyms |
|
|
| Definitions |
A naturally occurring serine derivative diazo compound with antineoplastic properties, Azaserine functions as a purine antagonist and glutamine analogue (glutamine amidotransferase inhibitor) that competitively inhibits pathways in which glutamine is metabolized. An antibiotic and antitumor agent, Azaserine is used in clinical studies as a potential antineoplastic agent. (NCI04) |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C289 |
|
| CAS_Registry |
115-02-6 |
|
| Chemical_Formula |
C5H7N3O4 |
|
| code |
C289 |
|
| Contributing_Source |
FDA |
|
| definition |
A naturally occurring serine derivative diazo compound with antineoplastic properties, Azaserine functions as a purine antagonist and glutamine analogue (glutamine amidotransferase inhibitor) that competitively inhibits pathways in which glutamine is metabolized. An antibiotic and antitumor agent, Azaserine is used in clinical studies as a potential antineoplastic agent. (NCI04) |
|
| FDA_UNII_Code |
87299V3Q9W |
|
| in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C177537 http://purl.obolibrary.org/obo/NCIT_C176424 http://purl.obolibrary.org/obo/NCIT_C128784 |
|
| Is_Value_For_GDC_Property | ||
| label |
Azaserine |
|
| Legacy Concept Name |
Azaserine |
|
| Maps_To |
Azaserine |
|
| NCI_Drug_Dictionary_ID |
39156 |
|
| NSC Number |
742 |
|
| PDQ_Closed_Trial_Search_ID |
39156 |
|
| PDQ_Open_Trial_Search_ID |
39156 |
|
| Preferred_Name |
Azaserine |
|
| prefixIRI |
NCIT:C289 |
|
| prefLabel |
Azaserine |
|
| Semantic_Type |
Pharmacologic Substance Nucleic Acid, Nucleoside, or Nucleotide Antibiotic |
|
| UMLS_CUI |
C0004480 |
|
| subClassOf |